The Medicines Company

Parsippany Troy Hills, United States Founded: 1996 • Age: 30 yrs Acquired By Novartis
Markets and developing drugs in areas of acute cardiovascular care, infectious disease care and perioperative care.

About The Medicines Company

The Medicines Company is a company based in Parsippany Troy Hills (United States) founded in 1996 was acquired by Novartis in November 2019.. The Medicines Company has completed 6 acquisitions, including Annovation, Incline Therapeutics and ProFibrix.

  • Headquarter Parsippany Troy Hills, United States
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
    Annovation

    & 5 more

  • Acquired by
    Novartis

    (Nov 24, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of The Medicines Company

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (01 Jan 2015)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2016 Amount Post-IPO - The Medicines Company Valuation

investors

Jan, 2015 Amount Post-IPO - The Medicines Company Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in The Medicines Company

The Medicines Company has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novartis. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
R&D focused on manufacturing of drugs for multiple therapeutic areas
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by The Medicines Company

The Medicines Company has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Annovation, Incline Therapeutics and ProFibrix. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Antibacterial drugs are discovered and developed to combat resistance.
2011
Biopharmaceutical innovations are developed by Annovation Biopharma in Cambridge.
2009
Hospital-focused specialty pharmaceuticals are developed for acute pain management.
2009
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - The Medicines Company

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

The Medicines Company Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of The Medicines Company

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about The Medicines Company

When was The Medicines Company founded?

The Medicines Company was founded in 1996 and raised its 1st funding round 19 years after it was founded.

Where is The Medicines Company located?

The Medicines Company is headquartered in Parsippany Troy Hills, United States. It is registered at Parsippany Troy Hills, New Jersey, United States.

What does The Medicines Company do?

The Medicines Company vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company markets Angiomax(R) (bivalirudin) for use in patients undergoing coronary angioplasty, and Cleviprex(R) (clevidipine butyrate) injectable emulsion for the reduction of blood pressure. It has two products in late stage development: cangrelor, an antiplatelet agent, and oritavancin, a semi-synthetic lipoglycopeptide antibiotic. The Companys pipeline also includes a serine protease inhibitor, CU2010, in early-stage development.

How many acquisitions has The Medicines Company made?

The Medicines Company has made 6 acquisitions, including Annovation, Incline Therapeutics, and ProFibrix.

Who are The Medicines Company's investors?

The Medicines Company has 1 investor. Key investors include Novartis.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available